NEW YORK, Dec. 22, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) pursuant and/or traceable to Kyverna's initial public offering conducted on February 8, 2024 (the "IPO"), of the...
Read More Details
Finally We wish PressBee provided you with enough information of ( KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. (NASDAQ: KYTX) Securities Fraud Lawsuit )
Also on site :
- The 36 US bases on the frontline of Iranian retribution
- Target's 'Top-Selling' $5 Backpack Is Heading Back to Stores This Year
- Fresh sirens in north Israel warning of Iran missiles: army